Insider Trading History of Manchester Keith S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Manchester Keith S since 2022. This trader's CIK number is 1244828. At the time of last reporting, Manchester Keith S was the Officer of Roivant Sciences Ltd.. (stock ticker symbol ROIV). Also see all insider trading activities at Roivant Sciences Ltd..

Note that in the past MANCHESTER KEITH S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Arbutus Biopharma Corp (ABUS) by Manchester Keith S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ABUS 0 $0 8,846 $32,641 54,915 $30,752

Yearly summary of insider trading at Roivant Sciences Ltd. (ROIV) by Manchester Keith S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ROIV 0 $0 503,000 $5,866,267 0 $0
2023 ROIV 0 $0 6,896,144 $79,650,463 0 $0
2022 ROIV 0 $0 3,922,504 $18,631,894 0 $0


Insider trading activities at 2 companies by Manchester Keith S:

1. Arbutus Biopharma Corp (ABUS)

2. Roivant Sciences Ltd. (ROIV)

Table 1. Insider trading of Arbutus Biopharma Corp (ABUS) by Manchester Keith S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-14 ABUS Sale 8,846 3.69 32,641
2024-08-14 ABUS Option Ex 54,915 .56 30,752

Table 2. Insider trading of Roivant Sciences Ltd. (ROIV) by Manchester Keith S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-09-24 ROIV Sale 368,052 11.62 4,278,604
2024-09-25 ROIV Sale 134,948 11.77 1,587,663
2023-09-28 ROIV Sale 6,896,144 11.55 79,650,463
2022-11-10 ROIV Sale 3,922,504 4.75 18,631,894

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Manchester Keith S (Officer of Roivant Sciences Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.